ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)Jens Hoeppner, J. R. Siewert, Thomas Brunner et al.|BMC Cancer|2016Cited by 352
The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center StudyHannah Fuellgraf, Peter Bronsert|Journal of Cancer|2017Cited by 2
Prognostic Impact of UBA1 Expression in Breast CancerJana Koch, Peter Bronsert|Journal of Cancer|2026Cited by 0